{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:43:50Z","timestamp":1764510230076},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1038\/sj.leu.2401819","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:36:05Z","timestamp":1031164565000},"page":"1310-1313","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure"],"prefix":"10.1038","volume":"14","author":[{"given":"P","family":"Tosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ronconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Benni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MR","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,7,17]]},"reference":[{"key":"BF2401819_CR1","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1001\/archinte.1990.00040031693017","volume":"150","author":"R Alexanian","year":"1990","unstructured":"Alexanian R, Barlogie B, Dixon D . Renal failure in multiple myeloma: pathogenesis and prognostic implications Arch Intern Med 1990 150: 1693\u20131695","journal-title":"Arch Intern Med"},{"key":"BF2401819_CR2","first-page":"147","volume":"28","author":"M Cavo","year":"1986","unstructured":"Cavo M, Baccarani M, Galieni P, Gobbi M, Tura S . Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients Nouv Rev Fr Hematol 1986 28: 147\u2013152","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF2401819_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1600-0609.1994.tb00190.x","volume":"53","author":"L Knudsen","year":"1994","unstructured":"Knudsen L, Hippe E, Hjorth M, Holmberg E, Westin J . Renal function in newly diagnosed multiple myeloma \u2013 a demographic study of 1353 patients Eur J Haematol 1994 53: 207\u2013212","journal-title":"Eur J Haematol"},{"key":"BF2401819_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R . A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91\u201397","journal-title":"New Engl J Med"},{"key":"BF2401819_CR5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V89.3.789","volume":"98","author":"B Barlogie","year":"1997","unstructured":"Barlogie B, Jagannath S, Vesole DH Nancke S, Cheson B, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, Tricot G . Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma Blood 1997 98: 789\u2013793","journal-title":"Blood"},{"key":"BF2401819_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/bjc.1981.52","volume":"43","author":"DS Alberts","year":"1981","unstructured":"Alberts DS, Chen HG, Benz D, Mason NL . Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalan Br J Cancer 1981 43: 330\u2013334","journal-title":"Br J Cancer"},{"key":"BF2401819_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/0277-5379(89)90138-7","volume":"25","author":"A Osterborg","year":"1989","unstructured":"Osterborg A, Ehrsson H, Eksberg S Wallin I, Mellstedt H . Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients Eur J Cancer Clin Oncol 1989 25: 899\u2013903","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF2401819_CR8","first-page":"475","volume":"66","author":"IGG Cornwell","year":"1982","unstructured":"Cornwell IGG, Pajak TF, McIntyre OR Kochwa S, Dosik H . Influence of renal failure on myelosuppressive effets of melphalan: Cancer and Leukemia Group B experience Cancer Treat Rep 1982 66: 475\u2013481","journal-title":"Cancer Treat Rep"},{"key":"BF2401819_CR9","first-page":"522","volume":"72","author":"M Pecherstrofer","year":"1994","unstructured":"Pecherstrofer M, Zimmer-Roth I, Weidinger S, Irsigler K, Halbmayer WM, Ulrich W, Fischer M, Baumgartner G . High-dose intravenous melphalan in a patient with multiple myeloma and oliguric renal failure Clin Invest 1994 72: 522\u2013525","journal-title":"Clin Invest"},{"key":"BF2401819_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bmt.1700848","volume":"20","author":"JM Rebibou","year":"1997","unstructured":"Rebibou JM, Caillot D, Casanovas RO Tanter Y, Maillard N, Solary E, Rifle G, Guy H . Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure Bone Marrow Transplant 1997 20: 63\u201365","journal-title":"Bone Marrow Transplant"},{"key":"BF2401819_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.bmt.1700950","volume":"20","author":"OF Ballester","year":"1997","unstructured":"Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenblein GJ . High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency Bone Marrow Transplant 1997 20: 653\u2013656","journal-title":"Bone Marrow Transplant"},{"key":"BF2401819_CR12","first-page":"947","volume":"2","author":"G Tricot","year":"1996","unstructured":"Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B . Safety of autotransplant with high-dose melphalan in renal failure: a pharmacokinetics and toxicity study Clin Cancer Res 1996 2: 947\u2013952","journal-title":"Clin Cancer Res"},{"key":"BF2401819_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s002770050499","volume":"78","author":"E Reiter","year":"1999","unstructured":"Reiter E, Kalhs P, Keil F, Rabitsch W, Gissingler H, Mayer G, Worel N, Lechner K, Greinix HT . Effects of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature Ann Hematol 1999 78: 189\u2013191","journal-title":"Ann Hematol"},{"key":"BF2401819_CR14","first-page":"145","volume":"3","author":"Force Chronic Leukemia-Myeloma Task","year":"1973","unstructured":"Chronic Leukemia-Myeloma Task Force . Proposed guidelines for protocol studies: II. Plasma cell myeloma Cancer Chemother Rep 1973 3: 145\u2013157","journal-title":"Cancer Chemother Rep"},{"key":"BF2401819_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ajh.2830330203","volume":"33","author":"R Alexanian","year":"1990","unstructured":"Alexanian R, Barlogie B, Tucker S . VAD-based regimens as primary treatment for multiple myeloma Am J Hematol 1990 33: 86\u201389","journal-title":"Am J Hematol"},{"key":"BF2401819_CR16","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D . Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation Br J Haematol 1998 102: 1115\u20131123","journal-title":"Br J Haematol"},{"key":"BF2401819_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bmt.1701654","volume":"23","author":"S Kulkarni","year":"1999","unstructured":"Kulkarni S, Rodriguez M, Lafuente A, Mateos P, Metha J, Singhal S, Saso R, Tait D, Treleaven JG, Powles RL . Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD) Bone Marrow Transplant 1999 23: 803\u2013807","journal-title":"Bone Marrow Transplant"},{"key":"BF2401819_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","volume":"93","author":"DS Siegel","year":"1999","unstructured":"Siegel DS, Desikan KR, Metha J, Singhal S, Fassas A, Munshi N, Anaissie E, Nancke S, Ayers D, Spoon D, Vesole D, Tricot G, Barlogie B . Age is not a prognostic variable with autotransplants for multiple myeloma Blood 1999 93: 51\u201354","journal-title":"Blood"},{"key":"BF2401819_CR19","first-page":"226","volume":"88","author":"CM Bagley","year":"1978","unstructured":"Bagley CM, Bostick FW, DeVita VT . Clinical pharmacology of cyclophosphamide Cancer Res 1978 88: 226\u2013233","journal-title":"Cancer Res"},{"key":"BF2401819_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1701062","volume":"21","author":"A Alegre","year":"1998","unstructured":"Alegre A, Diaz Mediavilla J, san Miguel J, Mart\u00ednez R, Garc\u00eda Lara\u00f1a J, Sureda A, Lahuerta JJ, Morales D, Blad\u00e9 J, Caballero D, De la Rubia J, Escudero A, D\u00edez Mart\u00edn JL, Hern\u00e1ndez Navarro F, Rif\u00f3n J, Odriozola J, Brunet S, De la Serna J, Besalduch J, Vidal MJ, Solano C, Leon A, S\u00e1nchez JJ, Mart\u00ednez Chamorro C, Fern\u00e1ndez Ra\u00f1ada JM . Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry Bone Marrow Transplant 1998 21: 133\u2013140","journal-title":"Bone Marrow Transplant"},{"key":"BF2401819_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.bmt.1701280","volume":"22","author":"M Cavo","year":"1998","unstructured":"Cavo M, Bandini G, Benni M, Gozzetti A, Ronconi S, Rosti GA, Zamagni E, Lemoli RM, Bonini A, Belardinelli A, Motta MR, Rizzi S, Tura S . High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma Bone Marrow Transplant 1998 22: 27\u201332","journal-title":"Bone Marrow Transplant"},{"key":"BF2401819_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF00558081","volume":"36","author":"M Hassan","year":"1989","unstructured":"Hassan M, Oberg G, Ehrsson H, Ehrnebo M, Wallin I, Smedyr B, Totterman T, Eksborg S, Simonsson B . Pharmacokinetic and metabolic studies of high-dose busulfan in adults Eur J Clin Pharmacol 1989 36: 525\u2013530","journal-title":"Eur J Clin Pharmacol"},{"key":"BF2401819_CR23","first-page":"476","volume":"66","author":"GG Cornwell","year":"1982","unstructured":"Cornwell GG, Pajak TF, McIntyre ER, Kochwa S, Dosik H . Influence of renal failure on the myelosuppressive effects of melphalan: cancer and leukemia group B experience Cancer Treat Rep 1982 66: 476\u2013482","journal-title":"Cancer Treat Rep"},{"key":"BF2401819_CR24","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1200\/JCO.1988.6.11.1768","volume":"6","author":"G Sarosy","year":"1988","unstructured":"Sarosy G, Leyland-Jones B, Soochan P, Cheson BD . The systemic administration of intravenous melphalan J Clin Oncol 1988 6: 1768\u20131782","journal-title":"J Clin Oncol"},{"key":"BF2401819_CR25","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V72.6.2015.bloodjournal7262015","volume":"72","author":"B Barlogie","year":"1988","unstructured":"Barlogie B, Alexanian R, Smallwood L, Cheson B, Dixon D, Dicke K, Cabanillas F . Prognostic factors with high-dose melphalan for refractory multiple myeloma Blood 1988 72: 2015\u20132019","journal-title":"Blood"},{"key":"BF2401819_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1200\/JCO.1994.12.4.759","volume":"12","author":"D Cunningham","year":"1994","unstructured":"Cunningham D, Paz-Ares L, Gore ME, Malpas J, Hickish T, Nicolson M, Meldrum M, Viner C, Milan S, Selby PJ . High-dose melphalan for multiple myeloma: long-term follow-up data J Clin Oncol 1994 12: 759\u2013763","journal-title":"J Clin Oncol"},{"key":"BF2401819_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","volume":"93","author":"B Barlogie","year":"1999","unstructured":"Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S, Mehta J, Anaissie E, Dhodapkar D, Naucke S, Cromer J, Sawyer J, Epstein J, Spoon D, Ayers D, Cheson B, Crowley J . Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 1999 93: 55\u201365","journal-title":"Blood"},{"key":"BF2401819_CR28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood.V87.4.1625.bloodjournal8741625","volume":"87","author":"RM Lemoli","year":"1996","unstructured":"Lemoli RM, Fortuna A, Motta MR, Rizzi S, Giudice V, Nanetti A, Martinelli G, Cavo M, Amabile M, Mangianti S, Fogli M, Conte R, Tura S . Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells Blood 1996 87: 1625\u20131634","journal-title":"Blood"},{"key":"BF2401819_CR29","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner RL, Schaffer RL, Lambert KW, Langer FP, Anasetti C, Bensinger WI, Fisher LD, Appelbaum FR . Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics Bone Marrow Transplant 1995 16: 31\u201342","journal-title":"Bone Marrow Transplant"},{"key":"BF2401819_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.bmt.1701763","volume":"23","author":"P Moreau","year":"1999","unstructured":"Moreau P, Milpied N, Mahe B Juge Morineau N, Rapp MJ, Bataille R, Harousseau JL . Melphalan 220mg\/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma Bone Marrow Transplant 1999 23: 1003\u20131006","journal-title":"Bone Marrow Transplant"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401819","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401819.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:42:55Z","timestamp":1648759375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["BF2401819"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401819","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,1]]},"assertion":[{"value":"25 February 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}